June 11, 2020 / 12:22 PM / a month ago

BRIEF-FDA Approves Pfizer's Oncology Supportive Care Biosimilar, Nyvepria

June 11 (Reuters) - Pfizer Inc:

* FDA APPROVES PFIZER’S ONCOLOGY SUPPORTIVE CARE BIOSIMILAR, NYVEPRIA™ (PEGFILGRASTIM-APGF)

* PFIZER - FDA APPROVAL WAS BASED ON TOTALITY OF EVIDENCE DEMONSTRATING HIGH DEGREE OF SIMILARITY OF NYVEPRIA TO ITS REFERENCE PRODUCT

* PFIZER - FDA HAS APPROVED NYVEPRIA A BIOSIMILAR TO NEULASTA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below